Skip to content

Beyond the A1c: Cardiovascular and Renal Benefits of Diabetes Medications

New literature has changed the structure of recommendations in the ADA Standards of Care in Diabetes and directly impacts pharmacy practice. When the right medication is selected for these patients, the pharmacist can help drive a reduction in cardiovascular mortality and progression of kidney disease. Pharmacists that are involved with treating diabetes will benefit from this presentation as the information presented details available primary literature and will help them guide therapy selection with patients.

Learning Objectives

Upon completion of this activity, the participant will be able to:

  • Differentiate microvascular and macrovascular complications of diabetes
  • Interpret the literature surrounding cardiovascular and renal benefits of diabetes medications
  • Identify the mechanism behind cardiovascular and renal benefits
  • Apply patient specific factors and primary literature to therapy selection for type 2 diabetes


Meissane Lee, PharmD is currently a PGY2 ambulatory care pharmacy resident at Boston Medical Center. She completed her PGY1 at Boston Medical Center and received her Doctor of Pharmacy from Northeastern University in 2019.

Andrew Swanner, PharmD is currently a PGY-2 Geriatric Pharmacy resident at VA Boston. He also completed his PGY-1 at VA Boston and received his Doctor of Pharmacy from the Medical University of South Carolina in Charleston, SC. He hopes to continue providing direct patient care through work as an ambulatory care pharmacist and one day work in academia.

Registration Fee: Free for MCPHS alumni, faculty and staff. For all others the fee is $12.00.


ACPE logo

Release Date: April 14, 2021
Expiration Date: April 29, 2022
Contact Hours: 1.0
Universal Activity Number: 0026-0000-21-003-H01-P
ACPE Topic Designator: Disease State Management/Drug Therapy


MCPHS University is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. MCPHS designates this educational activity for a total of 1.0 contact hours (.10 CEUs).

Requirements for Credit

In order to receive credit, the participant must review the entire presentation and complete the post-test and evaluation form. Upon completion participant credit will be reported to CPE Monitor. Transcripts may be printed from CPE Monitor.

Statement of Disclosure

MCPHS University adheres to the ACPE Standards regarding commercial support of continuing pharmacy education. It is the policy of MCPHS University that the speakers and planning committee disclose real or apparent conflicts of interest relating to the topics of the educational activity, that relevant conflicts of interest are resolved, and also that speakers will disclose any unlabeled/unapproved use of drugs or devices during their presentation.

No funding from industry provided for this event. No exhibitors will be present.
Meissane Lee, PharmD and Andrew Swanner, PharmD Urvinder Kaur, PharmD, have no relevant financial relationships to disclose.
All CE staff members have no relevant financial relationships to disclose.